Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;35(3):221-228.
doi: 10.1017/S0266462319000333. Epub 2019 Jun 13.

Population Adjustment Methods for Indirect Comparisons: A Review of National Institute for Health and Care Excellence Technology Appraisals

Affiliations

Population Adjustment Methods for Indirect Comparisons: A Review of National Institute for Health and Care Excellence Technology Appraisals

David M Phillippo et al. Int J Technol Assess Health Care. 2019 Jan.

Abstract

Objectives: Indirect comparisons via a common comparator (anchored comparisons) are commonly used in health technology assessment. However, common comparators may not be available, or the comparison may be biased due to differences in effect modifiers between the included studies. Recently proposed population adjustment methods aim to adjust for differences between study populations in the situation where individual patient data are available from at least one study, but not all studies. They can also be used when there is no common comparator or for single-arm studies (unanchored comparisons). We aim to characterise the use of population adjustment methods in technology appraisals (TAs) submitted to the United Kingdom National Institute for Health and Care Excellence (NICE).

Methods: We reviewed NICE TAs published between 01/01/2010 and 20/04/2018.

Results: Population adjustment methods were used in 7 percent (18/268) of TAs. Most applications used unanchored comparisons (89 percent, 16/18), and were in oncology (83 percent, 15/18). Methods used included matching-adjusted indirect comparisons (89 percent, 16/18) and simulated treatment comparisons (17 percent, 3/18). Covariates were included based on: availability, expert opinion, effective sample size, statistical significance, or cross-validation. Larger treatment networks were commonplace (56 percent, 10/18), but current methods cannot account for this. Appraisal committees received results of population-adjusted analyses with caution and typically looked for greater cost effectiveness to minimise decision risk.

Conclusions: Population adjustment methods are becoming increasingly common in NICE TAs, although their impact on decisions has been limited to date. Further research is needed to improve upon current methods, and to investigate their properties in simulation studies.

Keywords: Bias; Comparative effectiveness research; Effect modifier; Network meta-analysis; Technology assessment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

NJW is PI on a methodology grant jointly funded by the MRC and Pfizer Ltd. Pfizer part fund a junior researcher. The project is purely methodological and unrelated to this work.

DMP, SD, AE, and AEA declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart showing the process of selecting technology appraisals, and the numbers excluded and remaining at each stage.
Figure 2
Figure 2
The number and percentage of NICE technology appraisals using population adjustment methodology has increased greatly since the introduction of these methods in the literature in 2010. * Two TAs used population adjustment out of 25 up to 20th April 2018.
Figure 3
Figure 3
For technology appraisals in oncology, the number and percentage using population adjustment methodology has increased greatly since the introduction of these methods in the literature in 2010. * Two TAs used population adjustment out of 12 up to 20th April 2018.

References

    1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. Journal of Clinical Epidemiology. 1997;50:683–691. - PubMed
    1. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence Synthesis for Decision Making 2: A Generalized Linear Modelling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. Medical Decision Making. 2013;33:607–617. - PMC - PubMed
    1. Dias S, Ades AE, Welton NJ, Jansen JP, Sutton AJ. Network Meta-Analysis for Decision Making. John Wiley & Sons Inc; 2018. p. 488. - DOI
    1. Signorovitch JE, Wu EQ, Yu AP, et al. Comparative Effectiveness Without Head-to-Head Trials A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept. Pharmacoeconomics. 2010;28:935–945. - PubMed
    1. Caro JJ, Ishak KJ. No Head-to-Head Trial? Simulate the Missing Arms. Pharmacoeconomics. 2010;28:957–967. - PubMed